XML 384 R57.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment information - Geographical breakdown of revenues (Details) - EUR (€) € in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023
Geographical areas |  |  |
Revenue from contracts with customers | € 777,079 | € 782,517 | € 772,009
Revenue from contributions | 11,294 | 14,450 | 9,417
Total revenue | 788,373 | 796,967 | 781,426
Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 517,636 | 599,086 | 664,516
Revenue from contributions | 11,294 | 12,308 | 8,461
Total revenue | 528,930 | 611,394 | 672,977
Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 259,443 | 183,431 | 107,493
Revenue from contributions |  | 2,142 | 956
Total revenue | 259,443 | 185,573 | 108,449
USA |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 431,509 | 445,859 | 459,424
USA | Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 323,508 | 354,124 | 414,192
USA | Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 108,001 | 91,735 | 45,232
Germany |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 25,293 | 32,904 | 34,134
Germany | Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 25,293 | 32,904 | 29,297
Germany | Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers |  |  | 4,837
France |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 19,855 | 19,910 | 32,005
France | Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 19,783 | 19,910 | 32,005
France | Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 72 |  |
United Kingdom |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 61,724 | 92,517 | 86,368
United Kingdom | Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 61,724 | 92,437 | 86,368
United Kingdom | Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers |  | 80 |
Switzerland |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 161,613 | 109,043 | 64,924
Switzerland | Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 10,892 | 18,048 | 7,500
Switzerland | Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 150,721 | 90,995 | 57,424
Rest of the world |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 77,085 | 82,283 | 95,154
Rest of the world | Discovery & Preclinical Development |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | 76,436 | 81,662 | € 95,154
Rest of the world | Just - Evotec Biologics |  |  |
Geographical areas |  |  |
Revenue from contracts with customers | € 649 | € 621 |

X
- Definition Revenue from contributions + References No definition available. + Details
Name: | evo_RevenueFromContributions
Namespace Prefix: | evo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfGeographicalAreasLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 28 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 23 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 32 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 33 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 34 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard -URIDate 2025-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2025-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2025-03-27 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph B12 -Subparagraph b -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 82 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard -URIDate 2025-03-27 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard -URIDate 2025-03-27 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_Revenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Paragraph 114 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Paragraph 113 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_SegmentsAxis=evo_SharedRDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=evo_JustEvotecBiologicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_DE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_FR
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_GB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_CH
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=evo_RestOfWorldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |